Literature DB >> 20009491

Does prolactin induce apoptosis? Evidences in a prostate cancer in vitro model.

D Giuffrida1, A Perdichizzi, M C Giuffrida, S La Vignera, R D'Agata, E Vicari, A E Calogero.   

Abstract

BACKGROUND: Prolactin (PRL) regulates prostate growth and differentiation. Some studies have suggested that PRL has a pro-apoptotic effect on a myeloma cell line and in newt spermatogonia. The proliferative effect of PRL on prostate cancer cell lines is, however, a controversial area. AIM: On this account, we evaluated the effects of PRL on the prostate cancer cell lines LNCaP and PC3 apoptosis and proliferation.
MATERIALS AND METHODS: LNCaP and PC3 cells were exposed to increasing concentrations of PRL for 24, 48, 72 and 96 hours. Staining with propidium iodide (PI) and TUNEL assay followed by flow cytometry were used to detect apoptosis. LNCaP and PC3 proliferation was assessed by optical microscopy counting.
RESULTS: PRL induced a dose-dependent decrease of DNA content and an increase of DNA fragmentation in LNCaP after 96 hours of incubation. These effects were observed with physiological concentrations of PRL and were counteracted by a prolactin receptor antagonist. On the other hand, PRL did not have any effect on DNA content or fragmentation in PC3 cells. No effect of PRL on LNCaP and PC3 proliferation was found.
CONCLUSIONS: This study indicates that PRL induces apoptosis in the androgen-responsive cell line LNCaP, whereas no effect was observed in the androgen-insensitive PC3 cell line. These findings suggest that androgen responsiveness may be required for PRL to be effective on prostatic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009491     DOI: 10.1007/BF03346592

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266.

Authors:  Klara Gadó; Eva Pállinger; Péter Kovács; Edit Takács; István Szilvási; Béla E Tóth; György Nagy; Gyula Domján; András Falus
Journal:  Immunol Lett       Date:  2002-07-03       Impact factor: 3.685

2.  A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.

Authors:  W Y Chen; P Ramamoorthy; N Chen; R Sticca; T E Wagner
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

3.  Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.

Authors:  G Untergasser; H Rumpold; M Hermann; S Dirnhofer; G Jilg; P Berger
Journal:  Exp Gerontol       Date:  1999-04       Impact factor: 4.032

4.  Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

Authors:  S K Peirce; W Y Chen; W Y Chen
Journal:  J Endocrinol       Date:  2001-10       Impact factor: 4.286

5.  The survival effect of prolactin on PC3 prostate cancer cells.

Authors:  Alain Ruffion; Kaltoom A Al-Sakkaf; Barry L Brown; Colby L Eaton; Freddie C Hamdy; Pauline R M Dobson
Journal:  Eur Urol       Date:  2003-03       Impact factor: 20.096

Review 6.  Prolactin as an autocrine/paracrine growth factor in human cancer.

Authors:  Nira Ben-Jonathan; Karen Liby; Molly McFarland; Michael Zinger
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

7.  Prolactin stimulates transcription of aspartate aminotransferase in prostate cells.

Authors:  R B Franklin; D B Ekiko; L C Costello
Journal:  Mol Cell Endocrinol       Date:  1992-12       Impact factor: 4.102

8.  Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate.

Authors:  G S Prins
Journal:  Endocrinology       Date:  1987-04       Impact factor: 4.736

9.  Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.

Authors:  M F Lin; R Garcia-Arenas; Y C Chao; M M Lai; P C Patel; X Z Xia
Journal:  Arch Biochem Biophys       Date:  1993-01       Impact factor: 4.013

Review 10.  Effect of prolactin on the prostate.

Authors:  L C Costello; R B Franklin
Journal:  Prostate       Date:  1994       Impact factor: 4.104

View more
  3 in total

1.  Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.

Authors:  Esak Lee; Elena V Rosca; Niranjan B Pandey; Aleksander S Popel
Journal:  Int J Biochem Cell Biol       Date:  2011-09-06       Impact factor: 5.085

2.  STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells.

Authors:  Adrián Ramírez de Arellano; Edgar I Lopez-Pulido; Priscila A Martínez-Neri; Ciro Estrada Chávez; Renee González Lucano; Mary Fafutis-Morris; A Aguilar-Lemarroy; José F Muñoz-Valle; Ana Laura Pereira-Suárez
Journal:  Cancer Cell Int       Date:  2015-09-04       Impact factor: 5.722

3.  High expression of prolactin receptor is associated with cell survival in cervical cancer cells.

Authors:  Edgar I Lopez-Pulido; José F Muñoz-Valle; Susana Del Toro-Arreola; Luis F Jave-Suárez; Miriam R Bueno-Topete; Ciro Estrada-Chávez; Ana Laura Pereira-Suárez
Journal:  Cancer Cell Int       Date:  2013-10-22       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.